Key result
MCS and maximal medical therapy yields ~33% survival in fulminant myocarditis across diverse etiologies.
Why the study?
Although fulminant myocarditis often has a uniform clinical presentation, its underlying aetiology is heterogeneous and carries important implications for diagnosis, therapeutic strategy, and prognosis.
Case Report (n=3)
Fulminant myocarditis represents a haemodynamic phenotype rather than a final diagnosis, making systematic histological, virological, and genetic evaluation via endomyocardial biopsy essential for guiding management in mechanical circulatory support-dependent patients.
Answers are grounded in this paper and cite their sources.
May support biopsy for etiology in fulminant myocarditis needing support; hypothesis-generating for targeted therapies.
Background Fulminant myocarditis is a rare but life-threatening condition characterised by acute haemodynamic compromise, malignant arrhythmias, and rapid progression to cardiogenic shock. Although the clinical presentation is often uniform, the underlying aetiology is heterogeneous and carries important implications for diagnosis, therapeutic strategy, and prognosis. Case summary We report three patients presenting within months of each other with fulminant myocarditis of distinct aetiologies: eosinophilic myocarditis associated with amoxicillin-clavulanate in a 71-year-old male; lymphocytic myocarditis in a 25-year-old male with a posthumously identified pathogenic FLNC (Filamin C) variant; and lymphocytic myocarditis with extensive replacement fibrosis in a 68-year-old male. All three required mechanical circulatory support. Despite maximal therapy, two patients died and one survived with durable left ventricular assist device (LVAD) support. Conclusion Endomyocardial biopsy was pivotal in establishing the underlying diagnosis and guiding management, particularly in cases where cardiac magnetic resonance imaging (CMR) was technically limited. These cases illustrate that fulminant myocarditis represents a haemodynamic phenotype rather than a final diagnosis. Systematic histological, virological, and – where clinically indicated – genetic evaluation is essential, as aetiology informs management but does not reliably predict outcome in mechanical circulatory support (MCS) -dependent presentations.
No takes yet. Share an insight, caveat, or question.
König et al. (2026) conducted a case report in Fulminant myocarditis (n=3). Mechanical circulatory support and endomyocardial biopsy-guided management was evaluated on Survival. Mechanical circulatory support and maximal therapy in 3 patients with fulminant myocarditis of distinct aetiologies resulted in 1 survival (33.3%) with durable LVAD and 2 deaths (66.7%).
Synapse has enriched 10 related papers. Consider them for comparative context: